SEC Form 4 · accession 0001125857-15-000001
EASTGATE BIOTECH CORP · ETBI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anna E Gluskin
Director
Period of report
Jan 5, 2015
Accepted (ET)
Jan 21, 2015 · 2:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099574
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 5, 2015 | P | 1,243,750 | $0.04 | A | 12,193,688 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WARRANT | $0.04 | Jan 5, 2015 | P | 1,243,750 | A | Jan 5, 2015 | Jan 5, 2020 | COMMON STOCK | 1,243,750 | 2,251,750 | D |